Skip to content
Live funding
↑Microbiotica €42.7M Series C round led by British Business Bank ↑Goodweek €10.7M funding round led by Adara Ventures ↑Qilimanjaro Quantum Tech €19.6M raises a Series A round ↑Ambio €5.1M Seed round led by Lifeline Ventures ↑Duvo €28.5M Series A round led by Balderton Capital ↑Salience Labs €111.4M Series B round led by Bullhound Capital ↑Wavo €10M funding round led by Eurazeo ↑Cofrai €2.6M funding round led by DFF Ventures ↑Undecimal Bio €16M Seed round led by 4BIO Capital ↑Obsero €1M Seed round led by SFC Capital ↑ParkMundo €2.3M Seed round led by Rabobank ↑Ubitium €12.5M Seed round led by Ibex Investors ↑Alchera Technologies €3.2M Seed round led by Maven Capital Partners ↑Sainaptic €1.2M funding round led by Brighteye Ventures ↑reebuild €3M Seed round led by Rise PropTech ↑Causa Prima €17.9M Seed round led by Base10 Partners ↑Affinity Labs €1.8M Pre-seed round led by Antler ↑Epyr €15M Series A round led by SlateVC ↑CarbonFarm €7M Series A round led by Colam Impact ↑CMR Surgical €358.1M funding round led by Stryker
Sesame Summit 2027
Sesamers
SV Health Investors

SV Health Investors

● Actively deploying London, United Kingdom · Founded 1993

Investment thesis

SV Health Investors is a healthcare specialist investing from early stage through growth across therapeutics, medtech and healthcare growth equity. Working from London and Boston, it runs dedicated biotechnology, dementia, growth equity and medtech teams staffed by more than 50 investment professionals and operating partners, and has raised around $4.0 billion in commitments over three decades.

Past investments

Company Round Date Round size
Artios Cambridge, United Kingdom Series D+ Nov 2025 €105.8M

Sesamers coverage

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.